Reporte zur Charge EU6207

Symptomtext

Lots of back pain; Fever of 99 F; Severe arm soreness at injection location; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EU6207), via an unspecified route of administration in the left arm on 22Mar2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included inflammatory arthritis. Concomitant medications included sulfasalazine (SULFASALAZINE), methotrexate (METHOTREXATE), meloxicam (MELOXICAM) and folic acid (FOLIC ACID) all taken from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in 2021, the patient experienced a fever of 99-degree Fahrenheit for 4 hours, severe arm soreness at injection location (vaccination site pain), lots of back pain and fatigue. The events did not result in a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the events lots of back pain, fever of 99-degree Fahrenheit, severe arm soreness at injection location (vaccination site pain) and fatigue was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.